Design and synthesis of phthalimide-type histone deacetylase inhibitors

Bioorganic & Medicinal Chemistry Letters
2005.0

Abstract

Several hydroxamic acid derivatives with a substituted phthalimide group as a linker and/or cap structure, prepared during structural development studies based on thalidomide, were found to have histone deacetylase (HDAC)-inhibitory activity. Structure-activity relationship studies indicated that nature of the substituent introduced at the phthalimide nitrogen atom, introduction of a hydroxamic acid structure, and distance between the N-hydroxyl group and the cap structure are important for HDAC-inhibitory activity.

Knowledge Graph

Similar Paper

Design and synthesis of phthalimide-type histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2005.0
Synthesis and Biological Evaluation of 3-(4-Substituted-phenyl)-N-hydroxy-2-propenamides, a New Class of Histone Deacetylase Inhibitors
Journal of Medicinal Chemistry 2003.0
Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors
Bioorganic & Medicinal Chemistry Letters 2007.0
Synthesis and structure–activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group
Bioorganic & Medicinal Chemistry 2008.0
Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
Thiol-based SAHA analogues as potent histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors
Bioorganic & Medicinal Chemistry 2019.0
Design and synthesis of a novel class of histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0